1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AVROBIO Inc (AVRO)

  7. AVROBIO Inc (AVRO) News

AVRO

AVROBIO Inc
0.980049
-0.06995 (-6.66%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
AVROBIO Inc AVRO NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
-0.06995 -6.66% 0.980049 03:48:23
Open Price Low Price High Price Close Price Previous Close
1.05 0.94 1.08 1.05
more quote information »

Recent News

Date Time Source Heading
24/3/202307:59EDGARSecurities Registration: Employee Benefit Plan (s-8)
24/3/202307:37EDGARAnnual Report (10-k)
23/3/202322:12EDGARCurrent Report Filing (8-k)
23/3/202322:00BWAVROBIO Reports Fourth Quarter and Fiscal Year 2022..
03/3/202323:00BWAVROBIO to Participate in Cowen’s 43rd Annual Health Care..
28/2/202308:40EDGARCurrent Report Filing (8-k)
11/2/202309:18EDGARStatement of Changes in Beneficial Ownership (4)
11/2/202309:11EDGARStatement of Changes in Beneficial Ownership (4)
11/2/202309:10EDGARStatement of Changes in Beneficial Ownership (4)
11/2/202309:07EDGARStatement of Changes in Beneficial Ownership (4)
09/2/202323:00BWAVROBIO to Present Clinical and Preclinical Data from..
08/2/202322:05EDGARAmended Statement of Ownership (sc 13g/a)
27/1/202309:31EDGARStatement of Changes in Beneficial Ownership (4)
20/1/202309:11EDGARAmended Statement of Ownership (sc 13g/a)
05/1/202323:00BWAVROBIO Announces Inducement Grant Under Nasdaq Listing Rule..
10/12/202209:35EDGARStatement of Changes in Beneficial Ownership (4)
10/12/202209:33EDGARStatement of Changes in Beneficial Ownership (4)
10/12/202209:26EDGARStatement of Changes in Beneficial Ownership (4)
08/12/202220:25TRMNAvrobio (AVRO) Gets a Buy from Mizuho Securities
08/12/202206:25TRMNNeedham Reaffirms Their Buy Rating on Avrobio (AVRO)
07/12/202223:39EDGARCurrent Report Filing (8-k)
07/12/202223:30BWAVROBIO Announces New Positive Clinical Data and Outlines..
06/12/202209:15TRMNMizuho Securities Releases a Buy Rating on Avrobio (AVRO)
17/11/202223:00BWAVROBIO to Share Comprehensive Gaucher Disease Program..
10/11/202215:35TRMNMizuho Securities Sticks to Its Buy Rating for Avrobio..
09/11/202209:18EDGARSecurities Registration Statement (simplified Form) (s-3)
09/11/202208:33EDGARQuarterly Report (10-q)
08/11/202223:16EDGARCurrent Report Filing (8-k)
08/11/202223:00BWAVROBIO Reports Third Quarter 2022 Financial Results and..
07/11/202223:00BWAVROBIO to Participate in the Sixth Annual Barclays Gene..
03/11/202222:00BWAVROBIO Announces Inducement Grants Under Nasdaq Listing..
27/10/202222:00BWAVROBIO Receives Rare Pediatric Disease Designation from the..
26/10/202205:15TRMNNeedham Sticks to Its Buy Rating for Avrobio (AVRO)
25/10/202222:00BWAVROBIO Announces Completion of Patient Dosing in First Gene..
18/10/202222:00BWAVROBIO Granted ILAP Designation from U.K. MHRA for..
11/10/202222:00BWAVROBIO Reports Favorable Data on Use of Combined..
06/10/202222:00BWAVROBIO Announces Inducement Grants Under Nasdaq Listing..
27/9/202221:00BWAVROBIO to Present New Preclinical Data on Vector Safety at..
20/9/202221:54DJNAvroBio Gets Rare Pediatric Disease Designation for..
20/9/202221:00BWAVROBIO Receives Rare Pediatric Disease Designation from..
14/9/202221:28BWAVROBIO Announces Neuronopathic Mucopolysaccharidosis Type..
08/9/202221:00BWAVROBIO Announces Inducement Grants Under Nasdaq Listing..
31/8/202221:00BWAVROBIO to Participate in Four Upcoming Investor Conferences..
16/8/202218:48TRMNBTIG Sticks to Its Hold Rating for Avrobio (AVRO)
10/8/202206:33EDGARQuarterly Report (10-q)
10/8/202201:25TRMNMizuho Securities Reaffirms Their Buy Rating on Avrobio..
09/8/202221:13EDGARCurrent Report Filing (8-k)
09/8/202221:00BWAVROBIO Reports Second Quarter 2022 Financial Results and..
04/8/202221:00BWAVROBIO Announces Inducement Grants Under Nasdaq Listing..
01/8/202221:00BWAVROBIO to Participate in Two Upcoming Investor Conferences..
Your Recent History
NASDAQ
AVRO
AVROBIO
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230329 17:04:55